Anthelmintic drugs - PubMed (original) (raw)
Review
Anthelmintic drugs
Lindy Holden-Dye et al. WormBook. 2007.
Abstract
C. elegans is sensitive to the majority of anthelmintic drugs that are used against parasitic worm infections of humans and livestock. This has provided the opportunity to use molecular genetic techniques in the worm for mode of action studies. These approaches continue to be of considerable value to the field of parasitology. In addition, there are numerous examples of anthelmintic drugs providing exceptionally useful pharmacological tools to delineate fundamental aspects of cell signalling in C. elegans. This has primarily been achieved through the use of anthelmintics in forward genetic screens followed by the mapping and characterization of genes that confer altered susceptibility to the drug. Less fruitful so far, but nonetheless useful, has been the direct use of C. elegans for anthelmintic discovery programmes. In this brief review we provide an introduction to the use of C. elegans as a 'model parasite', outline the actions of the main classes of anthelmintics, and highlight approaches that have been of particular value.
Similar articles
- Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
Holden-Dye L, Walker RJ. Holden-Dye L, et al. WormBook. 2014 Dec 16:1-29. doi: 10.1895/wormbook.1.143.2. WormBook. 2014. PMID: 25517625 Free PMC article. Review. - Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
Blanchard A, Guégnard F, Charvet CL, Crisford A, Courtot E, Sauvé C, Harmache A, Duguet T, O'Connor V, Castagnone-Sereno P, Reaves B, Wolstenholme AJ, Beech RN, Holden-Dye L, Neveu C. Blanchard A, et al. PLoS Pathog. 2018 May 2;14(5):e1006996. doi: 10.1371/journal.ppat.1006996. eCollection 2018 May. PLoS Pathog. 2018. PMID: 29719008 Free PMC article. - Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.
Kaewintajuk K, Cho PY, Kim SY, Lee ES, Lee HK, Choi EB, Park H. Kaewintajuk K, et al. Parasitol Res. 2010 Jun;107(1):27-30. doi: 10.1007/s00436-010-1828-8. Epub 2010 Mar 23. Parasitol Res. 2010. PMID: 20309581 - Caenorhabditis elegans is a useful model for anthelmintic discovery.
Burns AR, Luciani GM, Musso G, Bagg R, Yeo M, Zhang Y, Rajendran L, Glavin J, Hunter R, Redman E, Stasiuk S, Schertzberg M, Angus McQuibban G, Caffrey CR, Cutler SR, Tyers M, Giaever G, Nislow C, Fraser AG, MacRae CA, Gilleard J, Roy PJ. Burns AR, et al. Nat Commun. 2015 Jun 25;6:7485. doi: 10.1038/ncomms8485. Nat Commun. 2015. PMID: 26108372 Free PMC article. - Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics.
Sepúlveda-Crespo D, Reguera RM, Rojo-Vázquez F, Balaña-Fouce R, Martínez-Valladares M. Sepúlveda-Crespo D, et al. Med Res Rev. 2020 Sep;40(5):1715-1753. doi: 10.1002/med.21668. Epub 2020 Mar 13. Med Res Rev. 2020. PMID: 32166776 Review.
Cited by
- Discovery of Cinnamylidene Derivative of Rhodanine with High Anthelmintic Activity against Rhabditis sp.
Tejchman W, Kołodziej P, Kalinowska-Tłuścik J, Nitek W, Żuchowski G, Bogucka-Kocka A, Żesławska E. Tejchman W, et al. Molecules. 2022 Mar 27;27(7):2155. doi: 10.3390/molecules27072155. Molecules. 2022. PMID: 35408557 Free PMC article. - The cholinomimetic morantel as an open channel blocker of the Ascaris suum ACR-16 nAChR.
Abongwa M, Baber KE, Martin RJ, Robertson AP. Abongwa M, et al. Invert Neurosci. 2016 Dec;16(4):10. doi: 10.1007/s10158-016-0193-4. Epub 2016 Dec 19. Invert Neurosci. 2016. PMID: 27995347 - Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases.
Hu Y, Miller MM, Derman AI, Ellis BL, Monnerat RG, Pogliano J, Aroian RV. Hu Y, et al. Appl Environ Microbiol. 2013 Sep;79(18):5527-32. doi: 10.1128/AEM.01854-13. Epub 2013 Jul 8. Appl Environ Microbiol. 2013. PMID: 23835175 Free PMC article. - Biogenic amines and the control of neuromuscular signaling in schistosomes.
Ribeiro P, Gupta V, El-Sakkary N. Ribeiro P, et al. Invert Neurosci. 2012 Jun;12(1):13-28. doi: 10.1007/s10158-012-0132-y. Epub 2012 Apr 18. Invert Neurosci. 2012. PMID: 22526557 Review. - Diisopropylphenyl-imidazole (DII): A new compound that exerts anthelmintic activity through novel molecular mechanisms.
Blanco MG, Vela Gurovic MS, Silbestri GF, Garelli A, Giunti S, Rayes D, De Rosa MJ. Blanco MG, et al. PLoS Negl Trop Dis. 2018 Dec 17;12(12):e0007021. doi: 10.1371/journal.pntd.0007021. eCollection 2018 Dec. PLoS Negl Trop Dis. 2018. PMID: 30557347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources